HAP Trading’s Asensus Surgical, Inc. ASXC Stock Holding History

HAP Trading’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-64,273	Closed	-$161K	–	2704
2021 Q1	$209K	Buy	+64,273	New	+$233K	0.01%	751

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HAP Trading's ASXC Position: Q2 2021 in Review

HAP Trading sold out of Asensus Surgical, Inc. (ASXC) in Q2 2021, closing a stake of 64,273 shares — an estimated $161K sold.

HAP Trading first reported a position in ASXC in Q1 2021 and held it in 1 quarter. The position peaked at $209K in Q1 2021. 119 funds tracked by Wall St. Rank hold ASXC as of Q2 2021.

HAP Trading reported no remaining Asensus Surgical, Inc. position as of Q2 2021 after selling out during the quarter.
HAP Trading sold 64,273 Asensus Surgical, Inc. shares in Q2 2021, an estimated $161K.
HAP Trading first reported a position in Asensus Surgical, Inc. in Q1 2021 and held it in 1 quarter.
HAP Trading's Asensus Surgical, Inc. position peaked at $209K in Q1 2021.
119 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2021.

Based on HAP Trading's 13F filing for Q2 2021, filed 11 Aug 2021.